Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Coronary Flow During Rapid Heart Rates

Sponsor: Imperial College London

NCT ID: NCT05841199

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Pressure and flow measurement during simulated VT (diagnostic test)
How long the study runs
Study runs about 34 months (dates as stated)
About the drug or intervention
Pressure and flow measurement during simulated VT — diagnostic test: Participants undergoing coronary angiography will have measurements of blood pressure, coronary pressure and coronary flow during simulated VT.
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
70
Started
2023-08-01
Last checked
2026-03

Plain English Summary

What is this study?

  • • Testing a new treatment for ventricular tachycardia
  • • Clinical study - 70 participants
  • • The goal of this observational study is to learn about the factors which determine how well ventricular tachycardia (VT) is tolerated

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with ventricular tachycardia

Where?

  • • London - Imperial College NHS Foundation Trust

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The goal of this observational study is to learn about the factors which determine how well ventricular tachycardia (VT) is tolerated. The main questions it aims to answer are: 1. What impact does coronary artery disease have on the ability for a patient to tolerate VT? 2. Does treatment of coronary artery disease with stents improve the tolerability of VT? Participants who are undergoing a clinically indicated coronary angiogram or coronary angioplasty procedure will have measurements of blood pressure, coronary pressure and coronary flow made during pacing at a range of heart rates.

More detail

Ventricular tachycardia (VT) is a common and life-threatening arrhythmia that occurs in people with heart problems. Some patients who develop this arrhythmia remain very stable with very little symptoms while others become unstable with low blood pressure or even sudden death. It is not known why some people tolerate the arrhythmia well and others do not. If VT is not tolerated then current practice is to offer an implantable cardioverter defibrillator (ICD) which can deliver a shock to the heart if dangerous heart rhythms are detected. While shocks can be life-saving, they are also harmful, including causing psychological distress. ICDs also frequently deliver shocks when they are not needed. If research could identify which factors predispose a person to be stable or unstable in VT, this would allow doctors to help them in a range of ways. One way would be to treat patients to improve the tolerance of VT, so avoiding the need for an ICD. Another would be to assess the the risk of instability and so allow a patient-centred decision on whether an ICD is needed. In this study the investigators plan to recruit patients who are referred for a coronary angiogram. During the angiogram, the investigators will stimulate the heart at a range of fast heart rates and measure their blood pressure and flow in their coronary arteries. In patients who undergo stenting for a coronary stenosis, the investigators will also make these measurements after stenting so they can see if there is any difference. By recruiting a range of different cardiology patients, the investigators will be able to assess which factors contribute to stability during VT.

Ventricular TachycardiaCoronary Artery DiseaseHeart FailureCoronary Microvascular DysfunctionCoronary Microvascular Disease

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Able to give valid consent
  • ✓Referred for coronary angiography or coronary angioplasty
  • ✓Suitable for percutaneous physiological interrogation and PCI when clinically indicated

Who cannot take part

  • ✗Unable to give valid consent
  • ✗Pregnant or breastfeeding women
  • ✗Unstable coronary artery disease (acute coronary syndrome)
  • ✗Severe multivessel coronary artery disease suitable for coronary artery bypass grafting
  • ✗Severe heart valve disease
See the full criteria
Inclusion Criteria: * Able to give valid consent * Referred for coronary angiography or coronary angioplasty * Suitable for percutaneous physiological interrogation and PCI when clinically indicated Exclusion Criteria: * Unable to give valid consent * Pregnant or breastfeeding women * Unstable coronary artery disease (acute coronary syndrome) * Severe multivessel coronary artery disease suitable for coronary artery bypass grafting * Severe heart valve disease * Severe (NYHA IV) heart failure

Where Is This Study? (1 UK site)

Imperial College NHS Foundation Trust

London W12 0HS, United Kingdom

Recruiting
Site contact (verified)
Ricardo Petraco, PhDPrincipal Investigator

How to Get in Touch

Rahul Bahl

Sponsor contact

CONTACT

+44 20 7594 1093 r.bahl@imperial.ac.uk

Ricardo Petraco

Sponsor contact

CONTACT

+44 20 7594 1093 r.petraco@imperial.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-03